density BMD

Related by string. * Density . DENSITY : bone density . low density lipoprotein . pixel density . density lipoprotein HDL . density lipoprotein HDL cholesterol . larger crorepati density . density lipoprotein cholesterol / BMS . BMED . bm . BMed . BMs . Bm : Sao Paulo BM . Bristol Myers Squibb BMS . FTSE BM . BMS Scuderia Italia . lumbar spine BMD . WH BM brand * mineral density BMD *

Related by context. All words. (Click for frequent words.) 61 lumbar spine BMD 61 mineral density 60 hip BMD 60 lumbar spine bone 60 femoral neck 59 vertebral fracture 59 osteopenic 58 bone mineral 58 mineral density BMD 58 femoral neck BMD 57 serum phosphate 57 serum calcium levels 57 bone resorption 56 serum triglycerides 56 serum uric acid 56 alendronate 56 creatinine clearance 56 nonvertebral 56 risedronate 56 serum phosphate levels 56 Bone Mineral Density 55 creatinine ratio 55 HAQ DI 55 BMD measurements 55 serum phosphorus 55 serum concentrations 55 urinary calcium 55 adiponectin levels 55 A1C levels 55 strontium ranelate 54 ACR# responses 54 baseline HbA1c 54 LS BMD 54 hip femoral neck 54 DAS# [002] 54 serum urate 54 serum markers 54 A1c levels 54 fasting plasma glucose FPG 54 serum aminotransferase levels 54 serum IGF 53 NPH insulin 53 DEXA scan 53 seropositive patients 53 ABC/3TC 53 magnesium intake 53 endometrial thickness 53 #.#mg/dL 53 serum PTH 53 risedronate Actonel 53 HBeAg seroconversion 53 nonfasting triglyceride levels 53 6MWD 53 serum urate levels 53 vertebral fractures 53 teriparatide 53 HbA1C levels 53 calcium intakes 53 Teriparatide 53 bioavailable testosterone 53 -#.# mg dL [001] 53 Crohn Disease Activity 53 glycosylated hemoglobin levels 53 CLA supplementation 53 intact parathyroid hormone 53 quantitative computed tomography 53 postmenopausal osteoporotic women 53 parathyroid hormone PTH 53 nonvertebral fractures 53 plus MTX 52 carotid IMT 52 fasting glucose levels 52 thickness CIMT 52 HbA1c levels 52 hsCRP levels 52 fasting triglyceride levels 52 N telopeptide 52 cTnT levels 52 metabolic parameters 52 serum testosterone 52 HbA1C 52 hemoglobin concentrations 52 HER2 expression 52 nonvertebral fracture 52 dehydroepiandrosterone sulfate 52 ibandronate 52 urate levels 52 flutamide 52 calcium supplementation 52 subtrochanteric 52 OGTT 52 colorectal adenomas 52 thiazide diuretics 52 postoperative mortality 52 biochemical markers 52 albumin excretion 52 bone density 52 abdominal adiposity 52 dose atorvastatin 52 morphometric vertebral fractures 52 glycated hemoglobin HbA1c 52 hemoglobin A1c levels 52 IV bisphosphonates 52 CrCl 52 endometrial carcinoma 52 Index CDAI 52 alendronate Fosamax 52 serum creatinine levels 52 virologic response 52 fasting plasma glucose 52 mammographic density 52 tibolone 52 postmenopausal hormone therapy 52 nmol liter 51 urinary calcium excretion 51 glycosylated hemoglobin HbA1c 51 hyperphenylalaninemia HPA due 51 EBRT 51 CVD mortality 51 urinary N telopeptide 51 Parathyroid hormone 51 BMD 51 thyroid hormone levels 51 HbA 1c levels 51 IPSS 51 HbA 1C 51 platelet reactivity 51 plasma triglycerides 51 serum folate 51 oral antidiabetic drugs 51 glycosylated hemoglobin 51 lactate dehydrogenase LDH 51 serum calcium 51 carotid intima media 51 DAS# scores 51 atypical fractures 51 CK MB 51 PSADT 51 spine BMD 51 ng dL 51 XIENCE V PROMUS Stent 51 pg mL 51 serum lipid levels 51 Insulin sensitivity 51 cortical bone 51 osteoporotic fracture 51 creatinine levels 51 Hb A1C 51 paclitaxel eluting stents 51 Hb levels 51 glycated hemoglobin levels 51 hemoglobin concentration 51 raloxifene Evista 51 aminotransferase levels 51 baseline serum creatinine 51 iPTH 51 colorectal adenoma 51 tertiles 51 hydroxyvitamin D levels 51 dietary calcium intake 51 HbA1c 51 alanine aminotransferase ALT 51 adenoma recurrence 51 hepatic enzymes 51 MADRS score 51 timepoint 51 μmol L 51 tamsulosin 51 #mg/day [002] 51 mL/min/#.# m 2 51 osteoblast activity 51 highest tertile 51 serum prostate 51 FASLODEX 51 serum potassium 51 urinary tract symptoms LUTS 51 insulin detemir 51 femoral neck bone 51 serum homocysteine 50 β blockers 50 atypical hyperplasia 50 aminotransferases 50 BMI z 50 serum lipid 50 osteoporosis osteopenia 50 skeletal muscle mass 50 alanine aminotransferase 50 non vertebral fractures 50 plasma folate 50 extrapyramidal symptoms 50 solifenacin 50 postmenopausal osteoporosis 50 hepatic fibrosis 50 CHD mortality 50 troponin T 50 Scale EDSS 50 urinary albumin 50 Calcium intake 50 OADs 50 lipid levels 50 left ventricular systolic 50 pCR 50 mucosal healing 50 placebo p 50 umol L 50 Hemoglobin A1c 50 ALT AST 50 ARIMIDEX 50 PSA nadir 50 fasting insulin 50 urine albumin 50 transaminases 50 dose oral contraceptives 50 oxycodone CR 50 specific alkaline phosphatase 50 transferrin saturation 50 Osteopenia 50 serum TSH 50 fasting triglycerides 50 PASI scores 50 lipid profiles 50 AGILECT R 50 hsCRP 50 thyrotropin levels 50 kg m² 50 titrated glipizide 50 Expanded Disability Status 50 neutrophil counts 50 tertile 50 DMPA 50 Bisphosphonates 50 subclinical hypothyroidism 50 oral FTY# 50 kg/m2 50 zoledronic acid 50 macroalbuminuria 50 Montgomery Asberg Depression 50 APTIVUS r 50 baseline A1C 50 Alendronate 50 timepoints 50 inflammatory biomarkers 50 Fasting glucose 50 TAXUS Express Stent 50 hypogonadal men 50 pioglitazone 50 hemoglobin Hb 50 plus medroxyprogesterone acetate 50 recurrent VTE 50 lipid lowering agents 50 log# copies mL 50 -#.# mg dL [002] 50 odanacatib 50 premenopausal 50 leukocyte count 50 paricalcitol 50 hemoglobin A1C 50 gastric pH 50 acetabular dysplasia 50 serum HBV DNA 50 carotid artery intima media 50 arterial thickening 50 oral antidiabetic medication 50 lispro 50 osteoporotic 50 GnRH agonist 50 p = #.# [002] 50 retinal thickness 50 BARACLUDE r 50 ejection fractions 50 fragility fracture 50 homocysteine levels 50 dose Iluvien 50 apolipoprotein A1 50 Zocor simvastatin 50 endometrial hyperplasia 49 Aclasta 49 hemoglobin A1c HbA1c 49 postmenopausal women 49 endometrial 49 Rating Scale MADRS 49 intima media thickness 49 antidiabetic drugs 49 baseline LDH 49 ARCOXIA 49 LVEF 49 deep venous thromboses 49 hypercalcemia 49 diastolic blood pressures 49 homocysteine concentrations 49 #OHD levels 49 intravesical therapy 49 serum PSA 49 nocturnal hypoglycaemia 49 per deciliter mg 49 nondiabetic patients 49 artery stenosis 49 cTnT 49 TT genotype 49 Score IPSS 49 P = .# 49 nulliparous women 49 binary restenosis 49 clodronate 49 postmenopausal 49 bisphosphonate 49 bisphosphonate drugs 49 #.#/#.# mmHg [001] 49 lipid lowering therapy 49 periprocedural MI 49 coadministration 49 urinary excretion 49 hs CRP 49 DEXA 49 Clinical Endocrinology & 49 aspartate aminotransferase 49 pathologic fractures 49 folate intake 49 adiponectin concentrations 49 advanced adenomas 49 Fibromyalgia Impact Questionnaire 49 preoperatively 49 hip trochanter 49 pg ml 49 CI -#.# 49 fasting blood glucose 49 #kg/m# 49 bilateral oophorectomy 49 osteoporotic fractures 49 LYSTEDA 49 cortical thickness 49 plasma glucose levels 49 T2DM 49 BENICAR HCT 49 parous women 49 protein excretion 49 oral ibandronate 49 definite stent thrombosis 49 glycated hemoglobin 49 STRIDE PD 49 skinfold thickness 49 glucose uptake 49 serum potassium levels 49 knee OA 49 progestins 49 sUA 49 density lipoprotein HDL cholesterol 49 coronary artery calcification 49 HDL Cholesterol 49 LV hypertrophy 49 lipid parameters 49 hematological parameters 49 8 OHdG 49 moderate renal impairment 49 systemic embolism 49 desvenlafaxine succinate 49 nondiabetic 49 #mg/day [001] 49 Index CDAI score 49 Androgen deprivation therapy 49 dalteparin 49 DAPT 49 pravastatin therapy 49 loop diuretics 49 glucocorticoid induced osteoporosis 49 #OHD 49 elevated triglycerides 49 triglyceride concentrations 49 incontinence episodes 49 mcg dose 49 thyroid stimulating hormone 49 normotensive 49 WOMAC pain 49 dyslipidaemia 49 dose cytarabine 49 Homocysteine levels 49 serum cholesterol 49 TNFalpha 49 aromatase inhibitor therapy 49 glomerular filtration 49 Fasting blood glucose 49 thickness IMT 49 endometriosis ovarian cysts 49 sUA levels 49 lipid elevations 49 Protelos 49 atherosclerotic progression 49 serum testosterone levels 49 FOLPI 49 Estrogen deficiency 49 liver enzymes ALT 49 arterial calcification 49 SHPT 49 lymphocyte count 49 serum vitamin D 49 lipoprotein levels 49 albumin excretion rate 49 #.#mmol L [001] 48 HbA 1c 48 CDAI score 48 #.#mmol L [002] 48 trabecular 48 glycemia 48 pathologic fracture 48 bone microarchitecture 48 prolactin levels 48 NIHSS 48 lobular involution 48 Thiazolidinediones 48 #mmHg [001] 48 bazedoxifene conjugated estrogens 48 lactate dehydrogenase 48 Estradiol 48 fractional anisotropy 48 serum triglyceride levels 48 tipranavir r 48 trabecular bone 48 hypothalamic amenorrhea 48 lowest tertile 48 REYATAZ r arm 48 density lipoprotein cholesterol 48 eGFR 48 Bone density 48 rs# [004] 48 lymph node metastasis 48 mammographic breast density 48 postprandial glucose 48 ventricular enlargement 48 g dL 48 octreotide LAR 48 androgen suppression therapy 48 postmenopausal hormones 48 plasma lipids 48 serum albumin 48 amenorrhea 48 vitamin D calcium 48 fluvastatin 48 cinacalcet 48 bone metastases 48 oral bisphosphonates 48 corrected QT interval 48 isoenzyme 48 liver transaminases 48 serum parathyroid hormone 48 liver histology 48 PREZISTA r 48 atherothrombotic events 48 specific antigen PSA 48 #mg/dL [001] 48 normal ULN 48 oophorectomy 48 HBeAg 48 atherogenic dyslipidemia 48 osteosarcomas 48 EpCAM expression 48 osteoporotic bone 48 pulmonary artery pressure 48 erythrocyte sedimentation rate 48 NOLVADEX 48 BRCA2 mutation carriers 48 obese postmenopausal 48 bisphosphonate therapy 48 TAXUS Stent 48 mTSS 48 urinary oxalate 48 fibrosis progression 48 neurocognitive function 48 postmenopausal hormone 48 breast cancer recurrence 48 serum ALT 48 estrogen metabolites 48 mmol l 48 mmHg diastolic 48 hepatic function 48 mycophenolate mofetil 48 aromatase inhibitors AIs 48 FOSRENOL R 48 index BMI 48 biochemical recurrence 48 hepatic fat 48 trochanter 48 EDSS score 48 impaired endothelial 48 statistical significance p 48 serum phosphorous 48 hormone therapy estrogen 48 uric acid levels 48 Fosamax alendronate 48 GnRH agonists 48 serum CRP 48 hypercholesterolaemia 48 GSTM1 48 leukocyte counts 48 SHBG levels 48 RBP4 levels 48 Novartis Reclast 48 fat vegan diet 48 vasomotor symptoms 48 Pioglitazone 48 hypogonadal 48 renal toxicity 48 aspartate aminotransferase AST 48 loop diuretic 48 ARIXTRA 48 angiotensin receptor blocker ARB 48 thromboembolic events 48 thromboprophylaxis 48 DAS# CRP 48 sulphonylureas 48 skin sterol 48 hydroxychloroquine 48 PREMPRO 48 atypical ductal hyperplasia 48 CLBP 48 total cholesterol LDL 48 PRADAXA 48 MMSE scores 48 anastrozole 48 left ventricular LV 48 LNG IUS 48 biochemical relapse 48 x ULN 48 pioglitazone Actos 48 CDAI 48 HMG CoA reductase inhibitors 48 Vagifem 48 residual platelet reactivity 48 c reactive protein 48 prepregnancy BMI 48 prevalences 48 LUTS 48 serum estradiol 48 QTcF 48 knee osteoarthritis 48 rhGH 48 severe renal impairment 48 COPAXONE R 48 CI #.#-#.# [001] 48 premenopausal women 48 phosphate binders 48 Hypertrophy 48 triiodothyronine 48 folate supplementation 48 Femara letrozole 48 LDL HDL 48 degarelix 48 poor metabolizers 48 thyroglobulin 48 cardiovascular morbidity 48 estrone 48 testosterone supplementation 48 etidronate 48 breast carcinoma 48 MMSE score 47 QTc 47 abdominal circumference 47 QTc intervals 47 Subgroup analyzes 47 tumor histology 47 AVANDIA 47 CNS LS 47 Health Assessment Questionnaire 47 carotid plaque 47 nonfasting triglycerides 47 acarbose 47 prednisone prednisolone 47 mg d 47 aldosterone antagonist 47 advanced adenoma 47 serum sodium levels 47 dietary calcium 47 transaminase levels 47 Patency 47 serum creatinine 47 -#.# ± [002] 47 SERMs 47 intravenous bisphosphonates 47 DXA 47 HRQOL 47 MetS 47 mm Hg diastolic 47 SCr 47 atypia 47 PHPT 47 macrovascular 47 FOSRENOL ® 47 tHcy 47 dose oral contraceptive 47 metformin sulfonylurea 47 % CI #.#-#.# [005] 47 Hazard Ratio HR 47 fructosamine 47 apolipoprotein B 47 viral load 47 hypoglycaemic episodes 47 RLS symptoms 47 postoperative radiographs 47 polyp recurrence 47 glucocorticoid 47 Lp PLA 2 47 postoperative pulmonary 47 HOMA IR 47 AUCs 47 CYP#D# inhibitor 47 Recurrence Score 47 C Reactive Protein 47 psychiatric comorbidities 47 Baseline characteristics 47 Postmenopausal Women 47 androgen deprivation 47 insulin glargine 47 serum leptin 47 LV ejection fraction 47 antihypertensive medications 47 thiazide diuretic 47 intima media thickness IMT 47 osteocalcin 47 concomitant medications 47 Triglyceride levels 47 SHBG 47 cystatin C 47 relapsed MM 47 carbohydrate diets 47 visceral adiposity 47 mRNA expression 47 serum retinol 47 rosuvastatin #mg 47 DEXA scans 47 TDF FTC 47 bone density measurements 47 body fatness 47 clopidogrel Plavix 47 urinary albumin excretion 47 Heavy menstrual bleeding 47 atheroma volume 47 serum folate concentrations 47 cervical lesions 47 DHEA supplementation 47 serum sodium 47 Breslow thickness 47 myocardial infarction stroke 47 LDL C 47 Aerobic fitness 47 asymptomatic carotid stenosis 47 osteoporosis 47 intestinal permeability 47 dapagliflozin plus 47 DRB1 * 47 dyspareunia 47 #.#ng/ml 47 vitamin D inadequacy 47 antibody titers 47 gadolinium enhanced 47 HDL C 47 cardiorespiratory fitness 47 HIV RNA 47 androgenic 47 corticosteroid induced 47 multivariable adjusted 47 prospectively defined 47 thiazolidinediones TZDs 47 dose clopidogrel 47 calcium phosphorus 47 Candesartan 47 microalbuminuria 47 CC genotype 47 antihypertensive therapy 47 elevated creatinine 47 plasma lipid 47 cellularity 47 cilostazol 47 insulin sensitizers 47 Severity Index PASI 47 vitamin D supplementation 47 p = .# [002] 47 Denosumab 47 left ventricular hypertrophy 47 serum BDNF 47 dose aspirin 47 Postmenopausal 47 symptomatic VTE 47 Calcium supplements 47 unfractionated heparin 47 Adequate vitamin D 47 Psoriasis Area 47 thromboembolic 47 estrogen deficiency 47 PCa 47 estradiol 47 International Prostate Symptom 47 CIMZIA TM 47 dose cohort 47 CIN3 47 left ventricular diastolic 47 post menopausal 47 systolic blood pressures 47 ADAS Cog 47 hydroxyvitamin D 47 clinically meaningful 47 folic acid supplement 47 nmol L 47 Montgomery Åsberg Depression 47 LDL particle 47 dairy calcium intake 47 hormone therapy HT 47 % Confidence Interval 47 mmol L 46 Calcium vitamin D 46 antiarrhythmic drug 46 hypertensives 46 confidence intervals CIs 46 mIU L 46 rs# [002] 46 Oestrogen 46 IELT 46 adalimumab 46 antioxidant enzyme 46 oral antidiabetes 46 alpha blocker 46 metreleptin 46 patients undergoing CABG 46 serum lipids 46 distant metastases 46 logistic regression analysis 46 myocardial ischemia 46 triacylglycerol concentrations 46 Bone Density 46 ligament laxity 46 salivary flow 46 nulliparous 46 #μg [001] 46 diastolic BP 46 spontaneous preterm delivery 46 axillary lymph nodes 46 HSCT 46 colorectal neoplasia 46 microbleeds 46 antiresorptive drugs 46 Ostarine 46 glycemic diet 46 subclinical atherosclerosis 46 improves glycemic 46 deep venous thrombosis 46 hyperintense lesions 46 UCP2 46 aggrecan 46 arterial elasticity 46 fasting glucose 46 radical prostatectomy RP 46 atypical subtrochanteric femur fractures 46 mIU ml 46 elevated triglyceride levels 46 central adiposity 46 growth hormone secretion 46 aminotransferase ALT 46 adrenal suppression 46 eplerenone 46 ghrelin concentrations 46 Premenopausal women 46 parathyroid hormone 46 sustained virological response 46 fragility fractures 46 T1 weighted images 46 Cmax 46 T1DM 46 SGRQ 46 Epidemiologic studies 46 irregular menstrual cycles 46 Vertebral fractures 46 lopinavir r 46 VADT 46 Risedronate 46 follicle stimulating hormone 46 #Gy 46 intraocular pressure IOP 46 glomerular filtration rate 46 CSBMs 46 Visual Analogue Scale VAS 46 oestradiol 46 Progestin 46 femoral neck fracture 46 Skin sterol 46 typical antipsychotics 46 statistically significant p = 46 PCWP 46 COPAXONE ® 46 hyperhomocysteinemia 46 prostate cancer CaP 46 cardiac autonomic 46 carotid artery stenting 46 PUFA intake 46 calcium intake 46 oncologic outcomes 46 ALT elevation 46 bupropion SR 46 Taxus Stent 46 F FLT 46 metabolic syndrome MetS 46 d4T 46 HGPIN 46 diuretic chlorthalidone 46 % CI #.#-#.# [002] 46 eosinophil count 46 antiresorptive agents 46 Ki# 46 pamidronate 46 improves insulin sensitivity 46 LV dysfunction 46 elevated ALT 46 antioxidant supplementation 46 hip fracture 46 coronary stenosis 46 sFlt 1 46 IBDQ 46 % CI #.#-#.# [006] 46 MnSOD 46 serum selenium 46 anovulatory infertility 46 pulmonary capillary wedge 46 hormone ablation 46 aldosterone antagonists 46 androgenic hormones 46 RoACTEMRA 46 nonoperative treatment 46 radiographic findings 46 angiotensin II receptor blocker 46 estimated glomerular filtration 46 lasofoxifene 46 metabolite concentrations 46 abnormal glucose tolerance 46 Intraocular pressure 46 multivessel disease 46 hormone binding globulin 46 rosuvastatin Crestor 46 extracapsular extension 46 mg dose 46 insulin degludec 46 bone metastasis 46 Viral load 46 D dimer 46 SUVmax 46 thiazolidinediones 46 nmol L. 46 T2 lesion volume 46 antidiabetic medication 46 rearfoot 46 echogenicity 46 antiangiogenic therapy 46 serum ferritin 46 hormone receptor negative 46 HIV HCV coinfected 46 zoledronic acid Zometa 46 ADAS cog 46 venlafaxine Effexor 46 Waist Circumference 46 thromboembolism 46 knee osteoarthritis OA 46 naturally occurring estrogen 46 leiomyomas 46 lipid lowering drugs 46 nmol l 46 chlorthalidone 46 irbesartan 46 non aspirin NSAIDs 46 lymph node involvement 46 cTnI 46 ATACAND 46 variceal bleeding 46 NHANES III 46 baseline FEV 46 HoLEP 46 radiographic progression 46 perimenopausal women 46 triglyceride concentration 46 IQR 46 HBV DNA 46 systolic dysfunction 46 LDL Cholesterol 46 p = #.# [004] 46 C telopeptide 46 ORENCIA 46 goserelin 46 Hb A1c 46 gestational diabetes mellitus GDM 46 thyroid stimulating hormone TSH 46 nondepressed 46 waist girth 46 B7 H3 46 ziprasidone 46 pmol L 46 EDSS scores 46 glucose tolerance 46 cystectomy 46 severe hypoglycaemia 46 vitamin D intakes 46 densitometry 46 atherogenic 46 laboratory abnormalities 46 treat menopausal symptoms 46 thromboembolic disease 46 radical nephrectomy 46 CYPHER ® Stent 46 lateral radiograph 46 carbohydrate oxidation 46 nonalcoholic steatohepatitis NASH 46 vastus lateralis 46 osteopenia 46 RBP4 46 radiographically 46 Insulin resistance 46 calculated creatinine clearance 46 Warner Chilcott Actonel 46 Reynolds Risk Score 46 detrusor 46 thrombotic events 46 Calcium supplementation 46 Bondronat 46 LY# [003] 46 mm Hg systolic 46 serum insulin 46 5-FU/LV 46 gadolinium enhancing 46 inhibin B 46 HDL cholesterol triglycerides 46 phytoestrogen intake 46 periprocedural 45 tocilizumab 45 XGEVA 45 vascular dysfunction 45 estrogen receptor negative 45 pelvic lymphadenectomy 45 statistically significant p 45 vulvovaginal atrophy 45 NNT = 45 -#.# log# 45 CYPHER Stent 45 % CI #.#-#.# [008] 45 bezafibrate 45 KIF6 carriers 45 carotid stenosis 45 MDRD equation 45 surgically induced 45 KETEK 45 Ophena TM 45 telomere lengths 45 prevalent vertebral fracture 45 QRS duration 45 cerebral oxygenation 45 arterial stiffening 45 NNRTI resistance 45 UACR 45 grade glioma 45 angiotensin converting enzyme 45 Degarelix 45 Invasive Breast Cancer 45 non inferiority 45 EVISTA 45 LRP5 45 p = 45 vascular endothelial 45 alpha blockers 45 x ray absorptiometry 45 denosumab 45 pravastatin Pravachol 45 -#.# log# copies mL 45 ARB telmisartan 45 hormone receptor status 45 ventricular myocardium 45 intraocular pressure 45 Oral contraceptives 45 serum HCV RNA 45 follicle stimulating hormone FSH 45 AUA Symptom Score 45 mEq L 45 μg dL 45 handgrip strength 45 protease inhibitor PI 45 channel blocker amlodipine 45 Faslodex 45 FDG uptake 45 ABCB1 45 nonhormonal 45 Lumbar spine 45 prostate TURP 45 secondary hyperparathyroidism 45 hepatic steatosis 45 μg L 45 euthyroid 45 androgen deficiency 45 intravaginal ejaculatory latency 45 Vitamin D supplementation 45 sensitivity specificity 45 BRCA1 mutation carriers 45 serum thyroglobulin 45 BMI waist circumference 45 synthetic progestin 45 vaginal progesterone gel 45 multivariate Cox 45 fasting serum

Back to home page